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Abstract
HIV-associated neurocognitive disorders (HAND) is characterized by development of cognitive, behavioral and motor
abnormalities, and occur in approximately 50% of HIV infected individuals. Our current understanding of HAND emanates
mainly from HIV-1 subtype B (clade B), which is prevalent in USA and Western countries. However very little information is
available on neuropathogenesis of HIV-1 subtype C (clade C) that exists in Sub-Saharan Africa and Asia. Therefore, studies to
identify specific neuropathogenic mechanisms associated with HAND are worth pursuing to dissect the mechanisms
underlying this modulation and to prevent HAND particularly in clade B infection. In this study, we have investigated 84 key
human synaptic plasticity genes differential expression profile in clade B and clade C infected primary human astrocytes by
using RT2 Profile PCR Array human Synaptic Plasticity kit. Among these, 31 and 21 synaptic genes were significantly ($3
fold) down-regulated and 5 genes were significantly ($3 fold) up-regulated in clade B and clade C infected cells,
respectively compared to the uninfected control astrocytes. In flow-cytometry analysis, down-regulation of postsynaptic
density and dendrite spine morphology regulatory proteins (ARC, NMDAR1 and GRM1) was confirmed in both clade B and C
infected primary human astrocytes and SK-N-MC neuroblastoma cells. Further, spine density and dendrite morphology
changes by confocal microscopic analysis indicates significantly decreased spine density, loss of spines and decreased
dendrite diameter, total dendrite and spine area in clade B infected SK-N-MC neuroblastoma cells compared to uninfected
and clade C infected cells. We have also observed that, in clade B infected astrocytes, induction of apoptosis was
significantly higher than in the clade C infected astrocytes. In conclusion, this study suggests that down-regulation of
synaptic plasticity genes, decreased dendritic spine density and induction of apoptosis in astrocytes may contribute to the
severe neuropathogenesis in clade B infection.
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Introduction
HIV is a neurotropic virus that directly invades the brain shortly
after infection. HIV replicates in brain macrophages and microglia
causing inflammatory and neurotoxic host responses. HIV can
also cause severe neurological disorders, collectively known as
HIV-associated neurocognitive disorders (HAND). HAND is
characterized by development of cognitive, behavioral and motor
abnormalities. HIV-1 displays wide genetic variation in global
distribution. It is classified into three groups (M, O and N) and
genetically into nine different subtypes (A–K). Of these, clades B
and C represent the majority (.86%) of circulating HIV-1
variants [1]. Clade B is predominant in North America, Western
Europe, and Australia, whereas clade C is common in Africa,
Latin America, and Asia. Prior to the widespread use of highly
active antiretroviral therapy (HAART), 20–30% of individuals
with advanced HIV-1 clade B infection displayed symptoms of the
most severe HAND disorder, HIV-associated dementia (HAD)
[2,3]. On the contrary, Satischandra et al (2000) [4] and few other
studies [5] have reported unusually very low incidence-about 1–
2% of HAD in HIV-1 clade C infected patients from India. Since
the widespread use of HAART, the incidence of HAD has
dramatically decreased; however, as many as 40–50% of HIV-
positive patients continue to suffer from HAND [6,7,8,9,10]. Since
autopsies are seldom performed in developing countries where
HIV-1 infection is mainly with clade C, our current understanding
of the pathophysiology and neuropathology of HIV-1 infection
emanated mainly from clade B. Therefore, very little information
is available on neuropathogenesis of clade C. It has been reported
that replication efficiency of clade C in in-vitro monocyte-derived
macrophages is significantly less than clade B isolates [11]. In the
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same study, authors have also reported less neurotoxicity in clade
C infected neuronal cells than clade B infected cells.
Microglia/macrophages are the most commonly infected cells
in the brain and serve as lifelong hosts for HIV [2,12,13]. A second
cellular target for HIV in the brain is astrocytes [14,15,16].
Astrocytes are the most abundant cell type in the brain [17] and
perform many essential functions, such as maintenance of a
homeostatic environment, bidirectional communication with
neurons [18] and immune functions within the nervous system.
The extensive synaptic interaction not only ensures that astrocytes
are able to fulfill their metabolic support roles but also positions
astrocytes to directly influence the structure and function of the
synapse. Indeed there is an increasing evidence that astrocytes play
an active role in controlling the number and strength of a neuron’s
synapses and thus may contribute to mechanisms underlying
synaptic plasticity [19]. Therefore, use of astrocytes in the HIV
infection studies may lead to better understanding of the
neuropathogenesis of HIV.
The brain recalls immediate events via short-term memories;
however, it must consolidate these events into long-term memory
for later recall. Memory consolidation requires synaptic plasticity
characterized by physical changes to, and gene expression changes
in, neuronal synapses. Synaptic plasticity studies have discovered
immediate-early genes (IEGs) that alter expression immediately
after neuronal events. IEGs mediate long-term potentiation (LTP),
a process that enhances synaptic connections and consolidates
memories. However, as not all events become long-term
memories, the opposite synaptic remodeling response, long-term
depression (LTD), also plays a central role in synaptic plasticity.
Gene expression changes associated with LTD yield physical
changes in the neuronal synapse that recycle receptors and either
enhance or inhibit synaptic connections. The synaptic plasticity
genes are categorized into different groups (Table 1). We
hypothesize that infection of clade B and C differentially express
the synaptic plasticity genes, alters the dendrite morphology and
also induce apoptosis in brain cells.
In this study, we have analyzed the expression of 84 human
synaptic plasticity genes central to synaptic alterations during
learning and memory in HIV-1 clade B and C infected primary
human astrocytes using human Synaptic Plasticity RT2 Profile
PCR Array. Till now, there are no reports of analysis of synaptic
plasticity gene expression profile in response to clade B and C
infection. This array includes IEGs and other genes important for
LTP and LTD, as well as key neuronal receptor genes and genes
important for synapse remodeling. From the list of down-regulated
synaptic density genes, we have further analyzed the expression of
respective proteins which plays an important role in the
maintenance of dendritic architecture and spine density i.e activity
regulated cytoskeleton protein (ARC), Glutamate receptor 1
(GRIN1)/N-methyl-D-aspartate receptors subunit 1 (NMDAR1)
and Glutamate receptor metabotropic 1 (GRM1) in both clade B
and clade C infected astrocytes and SK-N-MC neuroblastoma
cells. Dendritic spines are the postsynaptic specializations and
believed to regulate the strength of synaptic transmission and play
critical role in neuronal plasticity. We have also observed the
significant spine density and dendrite morphology changes in
HIV-1 clade B and C infected SK-N-MC cells using confocal
microscopy. In HIV infected patients, altered dendritic spine
density may also attribute for the increased incidence of
neurocognitive disorders (HAND). Induction of apoptosis in
HIV-1 infected neuronal cells has been reported earlier [20]. In
this study, we have found that the induction of apoptosis was
significantly higher in clade B infected astrocytes than in clade C
infected cells.
Materials and Methods
Cell culture and reagents
Primary human astrocytes were purchased from ScienCell
Research laboratories (Carlsbad, CA; Cat. # 1800-5) and grown
in astrocyte medium purchased from ScienCell laboratories (Cat.
# 1801) containing 2% of fetal bovine serum (ScienCell Cat. #
0010), astrocyte growth supplement (ScienCell Cat. # 1852) and
penicillin/streptomycin (ScienCell Cat. # 0503). Human neuro-
blastoma SK-N-MC cells were obtained from ATCC (ATCC Cat
# HTB-10). HIV-1Ba-L (clade B) (NIH AIDS Reagent Program
Table 1. Functional Grouping of Human Synaptic Plasticity genes.
1. Immediate-Early Response Genes (IEGs) ARC, BDNF, CEBPB, CEBPD, CREB1, CREM, EGR1, EGR2, EGR3, EGR4, FOS, HOMER1,
JUN, JUNB, KLF10, MMP9 (Gelatinase B), NFKB1, NFKBIB (TRIP9), NGF, NPTX2, NR4A1,
NTF3, PCDH8, PIM1, PLAT (tPA), RELA, RGS2, RHEB, SRF, TNF
2. Late Response Genes INHBA, SYNPO.
3. Long Term Potentiation (LTP) ADCY1, ADCY8, BDNF, CAMK2A, CAMK2G, CDH2 (N-cadherin), CNR1, GABRA5, GNAI1,
GRIA1, GRIA2, NMDAR1 (GRIN1/NR1), GRIN2A, GRIN2B, GRIN2C, GRIN2D, MAPK1,
MMP9 (Gelatinase B), NTF4, NTRK2, PLCG1, PPP1CA, PPP1CC, PPP3CA, PRKCA, PRKCG,
RAB3A, YWHAQ (14-3-3).
4. Long Term Depression (LTD) GNAI1, GRIA1, GRIA2, GRIA3, GRIA4, GRIP1, GRM1, GRM2, IGF1, MAPK1, NOS1, NGFR,
PICK1, PLAT (tPA), PPP1CA, PPP1CC, PPP1R14A (CPI-17), PPP2CA, PPP3CA, PRKCA,
PRKG1
5. Cell Adhesion ADAM10, CDH2 (N-cadherin), GRIN2A, GRIN2B, NCAM1, PCDH8, PPP2CA, RELN, TNF.
6. Extracellular Matrix & Proteolytic Processing ADAM10, MMP9 (Gelatinase B), PLAT (tPA), RELN, TIMP1
7. CREB Cofactors AKT1, CAMK2G, NMDAR1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, MAPK1 (ERK2), PPP1CA,
PPP1CC.
8. Neuronal Receptors EPHB2, GABRA5, GRIA1, GRIA2, GRIA3, GRIA4, NMDAR1, GRIN2A, GRIN2B, GRIN2C,
GRIN2D, GRM1, GRM2, GRM3, GRM4, GRM5, GRM7, GRM8, NTRK2.
9. Postsynaptic Density ADAM10, ARC, DLG4 (PSD95), GRIA1, GRIA3, GRIA4, NMDAR1, GRIN2A, GRIN2B,
GRIN2C, GRM1, GRM3, HOMER1, PICK1, SYNPO.
10. Others KIF17, SIRT1.
doi:10.1371/journal.pone.0061399.t001
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Cat. # 510) and HIV-1-98CN006 (clade C) (NIH AIDS Reagent
Program, Cat. # 4164) were obtained through AIDS Research
and Reference Reagent Program, Division of AIDS, NIAID, NIH.
HIV-1 infection of primary human astrocytes and SK-N-
MC human neuroblastoma cells
Primary human astrocytes and SK-N-MC human neuroblasto-
ma cells were infected with HIV-1 using the previously described
protocol [21,22] with slight modifications. Briefly, astrocytes
(16106 cells) and SK-N-MC (16106 cells) cells were cultured
overnight in T-75 flasks using astrocyte medium and minimum
essential medium, respectively. The cells were activated by treating
with polybrene (10 mg/ml) for 6–7 hrs before the infection. The
cells were infected with TCID50 of HIV-1 clade B and C virus
(dose that produces approximately same levels of P24 antigen in
culture) for 7–10 days under same experimental conditions. On
every second day, half of the medium was replaced with the fresh
medium and the supernatant obtained from the used medium was
used for the p24 antigen estimation using ELISA kit (ZeptoMetrix
Corp. Cat # 0801200). Controls cells (without clade B or clade C)
were included in the set-up of all experiments.
mRNA isolation and first strand cDNA synthesis
After 7 days of clade B/clade C infection, primary human
astrocytes were harvested and the pellet was used for the mRNA
isolation using illustra triplePrep Kit (GE Healthcare Life Sciences,
UK; Cat # 28-9425-44) and on-column DNase treatment step
was also performed in the procedure. Purity of the RNA was
measured by microspot RNA reader (Synergy HT Multi-Mode
Microplate Reader from BioTek, US) and RNAs with an
OD260 nm/OD280 nm absorbance ratio of at least 2.0 were
used for PCR array. This mRNA was also used for the long
terminal repeat (LTR)-gene expression using RT-qPCR to
measure the HIV infectivity. One microgram of RNA (Control,
clade B and clade C infected) was used for the first strand cDNA
synthesis using SABiosciences’s RT2 First Strand Kit (Cat #
330401) as per supplier’s protocol. Genomic DNA elimination step
was performed before going for reverse transcription.
Human Synaptic Plasticity RT2 Profile PCR Array
Synaptic plasticity gene profiling was done using 96 well format
RT2 Profile PCR Array human Synaptic Plasticity kit (SABios-
ciences, Cat # PAHS-126A-2) using Stratagene Mx3000p qRT-
PCR instrument. The human Synaptic Plasticity RT2 Profiler
PCR Array interrogates 84 genes related to the human synaptic
plasticity. This kit was chosen because it includes diverse genes
important in the human synaptic plasticity, including Immediate-
Early Response (n = 30), Late Response (n = 2), Long Term
Potentiation (n= 28), Long Term Depression (n= 21), Cell
Adhesion (n= 9), Extracellular Matrix & Proteolytic Processing
(n = 5), CREB Cofactors (n = 10), Neuronal Receptors (n = 19),
Postsynaptic Density (n = 15), as well as other genes involved in the
synaptic plasticity (n = 2). Few genes have role in multiple
functions listed above. The array was performed in three
independent set of experiments. Relative abundance of each
mRNA species was assessed using RT2 SYBR Green/ROX PCR
Master mix (SABiosciences, Cat # 330520) and aliquoted in equal
volumes (25 ml) to each well of the real-time PCR arrays. The real-
time PCR cycling program (as indicated by the manufacturer) was
run on a Stratagene Mx3000p qRT-PCR thermal cycler. The
threshold cycle (Ct) of each gene was determined by using the
Stratagene MaxPro software. The threshold and baseline were set
manually according to the manufacturer’s instructions. Ct data
were uploaded into the data analysis template on the manufac-
turer’s website (http://pcrdataanalysis.sabiosciences.com/pcr/
arrayanalysis.php). The relative expression of each gene in clade
B or clade C infected primary human astrocytes was calculated
using DDCT method with five housekeeping genes and compared
with the expression in control cells. Controls are also included on
each array for genomic DNA contamination, RNA quality, and
general PCR performance.
Flow-cytometry
In another set of experiment, astrocytes and SK-N-MC
neuroblastoma cells were infected with HIV-1 clade B and C.
Cells were probed with flow cytometry antibodies for dendritic
spine density and dendritic architecture regulated proteins i.e
ARC (Bioss antibodies, Cat # bs-0385R-PE-Cy5), NMDAR1
(GRIN1/NR1) (Santa Cruz Biotechnology, Cat # sc-1467-PE)
and GRM1 (Bioss antibodies, Cat # bs-1803R-AF647). In brief,
cells were washed with FACS buffer and probed with the
respective antibodies as indicated in the user manual and
incubated at room temperature (RT) for 20 min in the dark.
Probed cells were washed with the FACS buffer and fixed with 2%
paraformaldehyde and analyzed by FACScalibur within 1 hr.
Measurement of spine density and dendrite morphology
DiI staining. Established protocols to stain the neuronal cells
and measurement of the spine density were used with few
modifications [23,24,25]. In brief, SK-N-MC neuroblastoma cells
were grown in Eagle’s minimal essential medium containing 10%
fetal bovine serum, 5 mM sodium pyruvate, 100 units/ml
penicillin, 100 mg/ml streptomycin and retinoic acid at 37uC
with 5% CO2. SK-N-MC cells were grown onto 22 mm650 mm
glass coverslips placed in a petri-dish. Cells were treated with
polybrene for 8 hrs followed by addition of clade B/C virus. After
7 days of infection, cells were fixed with 4% Formaldehyde in PBS
for 30 min at RT. The fluorescent membrane tracer 1, 19-
Dioctadecyl-3, 3,39,39-tetramethylindocarbocyanine perchlorate
(DiI) at 7.5 mg/ml (in PBS) concentration was directly added onto
the fixed cultures and allowed to incubate for 90 min at RT.
These stained coverslips were placed overnight at 4uC in petri
dishes containing PBS before proceeding for confocal microscopy.
Confocal Microscopy. Confocal images were obtained using
TCS SP2 Confocal Laser Scanning Microscope (Leica Micro-
systems, Germany) at 488 nm (100%) illusion of an argon-ion laser
using 60X oil immersion objectives with high numeric aperture
and 2.5X confocal electronic zoom settings to visualize individual
cells and dendrites. Twenty Optical serial sections of 0.14 mm/
section (,2.8 mm total) through the cells were captured and
reconstructed to yield complete ‘‘two dimensional’’ images of
individual cells in focus.
Detection of Apoptosis
Seven days after infection with clade B and C, primary human
astrocytes were washed twice with cold PBS and then re-
suspended in 1X binding buffer at a concentration of 16106
cells/ml. From this, 100 ml was added to 5 ml FACS tubes,
followed by incubation with 5 ml each of Annexin V and 7-AAD
for 15 minutes at RT in the dark. After incubation, 400 ml of 1X
binding buffer was added to each tube, mixed gently and analyzed
by FACScalibur within 1 hr. The untreated population was used
for defining the basal level of apoptotic and dead cells. The
percentage of cells that have been induced to undergo apoptosis
was then determined by subtracting the percentage of apoptotic
cells in the untreated population from percentage of apoptotic cells
Synaptic Plasticity & Spine Density-HIV Infection
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in the treated population. Cells treated with camptothecin for
5 hrs at 37uC was used as positive control.
Data Analysis
In the expression studies, a gene was considered differentially
regulated if the difference was $3 fold in comparison with the
control. Experiments were performed at least three times and the
values obtained were averaged. All the results were expressed as
mean 6 s.e.m. Statistical analysis of two groups was performed by
Student’s t test, while more than two groups were analyzed using
one way ANOVA followed by Bonferroni’s multiple comparison
test. Differences were considered significant at p#0.05. Data
analysis was performed with the Statistical Program, GraphPad
Prism software (La Jolla, CA).
ImageJ software program was used to quantify DiI-labeled cells
(Figure 1). Dendritic segments were chosen randomly from the
apical and basal regions and at least one soma’s length away from
the cell soma. Six parameters were measured, including total
dendrite area, dendrite diameter, spine density (number of spines
divided by the dendrite length), spine area and spine length [25].
Results
Human Synaptic plasticity genes expression in primary
human astrocytes after infection with clade B and clade C
Total 84 key human synaptic plasticity genes were analyzed in
the RT2 Profile human Synaptic Plasticity PCR Array and fold
change in the gene expression profile in clade B and clade C
infected astrocytes was analyzed. The results were plotted in
scatterplot analysis graph (Figure 2a and 2b). Out of 84 genes
investigated, total 21 genes were significantly ($3 fold) down-
regulated (Table 2) in clade C infected cells compared to control
cells and 5 synaptic plasticity genes (EGR2, EGR4, HOMER1,
INHBA, SYNPO) were significantly up-regulated (Table 3) in both
clade B and C infected cells. In clade B infected cells, along with
the genes down-regulated in clade C infected cells, additionally 10
other synaptic plasticity genes (total 31 genes) were also down-
regulated than control uninfected cells (Table 2). All these genes
were functionally categorized into 10 groups. The fold down
regulations for clade B affected genes were higher (range 3–33
fold) compared to clade C affected genes (range 3–28 fold) with
respect to control.
Decreased postsynaptic density regulated proteins (ARC,
NMDAR1 and GRM1) in CNS cells
In flow cytometry analysis, expression levels of synaptic density
and dendritic architecture regulating proteins ARC (p,0.001 and
0.02), NMDAR1 (p,0.007 and 0.005) and GRM1 (p,0.006 and
0.04) were significantly decreased in HIV-1 clade B infected
primary human astrocytes than the control and clade C infected
cells, respectively. In clade C infected cells as well, these three
proteins (ARC, NMDAR1 and GRM1) were significantly down-
regulated than control astrocytes (p,0.02, 0.006, 0.01, respec-
tively). Representative figures showing differential protein expres-
sion were presented in Figure 3. Similarly, we have also observed
significantly decreased expression of ARC, NMDAR1 and GRM1
proteins in clade B and C infected SK-N-MC neuroblastoma cells
than the control cells (data not shown).
Figure 1. Neuronal dendrite and spine measurement by Image J analysis. A typical dendrite segment from a pyramidal neuron is shown,
and the six quantification parameters labeled as follows. 1) Total dendrite area is measured by drawing a box around the whole image; 2) dendrite
diameter is obtained by drawing a line across the dendrite thickness at a place of average width; 3) spine density is the total number of spines divided
by the dendrite length; 4) spine area is measured by drawing a box around the whole spine; 5) Dendrite length uses the broken line tool to measure
the length and 6) Spine length. (Smith et al., 2009. Reversal of long-term dendritic spine alterations in Alzheimer disease models. Proc Natl Acad Sci U
S A 106: 16877-16882. Copyright (2009) National Academy of Sciences, U.S.A.)
doi:10.1371/journal.pone.0061399.g001
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Altered dendritic architecture in clade B and clade C
infected SK-N-MC cells
SK-N-MC dendrite morphology of control (Fig. 4a), HIV-1
clade B (Fig. 4b) and clade C (Fig. 4c) infected cells were captured
using confocal microscopy and morphological changes were
analyzed using the established protocol [25]. Infection of SK-N-
MC cells with clade B and C resulted in significant decrease in
total dendrite area (p,0.007, p,0.04) (Figure 5a), spine density
(p,0.001, p,0.001) (Fig. 5b), dendrite diameter (p,0.016,
p,0.02) (Fig. 5c), spine area (p,0.01, p,0.01) (Fig. 5d), spine
length (p,0.002, p,0.01) (Fig. 5e) and number of spines
(p,0.002, p,0.02) (Fig. 5f) compared with uninfected control
cells, respectively. In clade B infected cells, except dendrite length
(p,0.16), significant decrease in dendrite area (p,0.001), spine
density (p,0.001), dendrite diameter (p,0.04), number of spines
(p,0.02), spine length (p,0.01) and spine area (p,0.01) was
observed than with clade C infected cells.
Induction of apoptosis in HIV-1 clade B and clade C
infected astrocytes
As shown in Figure 6, the percentages of apoptotic cells were
significantly higher in both clade B (41%, p,0.001) and clade C
infected cells (22.4%, p,0.003) compared to uninfected cells.
Compared to the clade B infected cells, apoptosis induction was
significantly lower (p,0.005) in clade C infected cells. Taken
together, these results suggested that the clade B infection being
the most neurotoxic to primary human astrocytes than clade C.
Discussion
In this study, in clade B infected astrocytes, we have observed
down-regulation of 31 key synaptic plasticity genes and dysregu-
lation of many other synaptic plasticity genes than the control and
clade C infected cells. In clade C infected astrocytes, total 21
synaptic plasticity genes (also down-regulated in clade B infected
cells) were down-regulated compared to the control cells. It
indicates that clade B is more neuropathogenic than clade C by
down-regulating the more number of synaptic plasticity genes and
in higher folds. Interestingly five genes (EGR2, EGR4, HOMER1,
INHBA, SYNPO) were significantly up regulated in both clade B
and C infected astrocytes compared to uninfected astrocytes and
the significances of these genes are yet to be elucidated. Gene
profiling studies have shown that HIV-Tat down-regulates genes
involved in the Ras-Raf-MEK1 signaling [26], a pathway involved
in modulating synaptic plasticity [27]. In one of the gene
dysregulation studies in HIV encephalitis patients, down-regula-
tion of synaptic plasticity genes has been reported [28]. Recently
from our lab, increased levels of HDAC2 in HIV-1 Tat treated
SK-N-MC cells was reported [29]. Chromatin remodeling due to
the increased levels of HDAC2 may explain the differential
expression of synaptic plasticity genes in HIV infected cells. Each
synaptic gene we have studied has one or more synaptic functions
among the 10 functional categories. The 5 highly down regulated
synaptic plasticity genes were GRIA1 (41 & 28 fold), PPP1CA (32
and 18 fold), NGFR (23 and 16 fold), NPTX2 (18 and 27 fold) and
AKT (15 and 6 fold) in clade B and C infected astrocytes,
respectively. Interestingly, in this study, we have observed 27 fold
down-regulation of NPTX2 gene expression in clade C infected
astrocytes. Whereas in clade B infected cells, NPTX2 was down-
regulated by 19 fold. Neuronal pentraxin 2 protein is also being
referred to as neuronal activity-regulated pentraxin, a secreted
protein with features of a calcium dependent lectin, which acts as a
neurotrophic factor promoting neuronal migration, synapse
formation and dendritic outgrowth of neurons with the same
potency as neurotrophins and growth factors [30,31,32]. Down-
regulation of NPTX2 may leads to decreased dendritic outgrowth
and synapse formation, and thereby it may have negative
regulatory effect on learning and memory. It is possible that some
unexplained functions may be associated with NPTX2 gene and
further studies on this gene with respect to clade B/C infections
and associated neuronal activation need to be elucidated in future
studies. If we see the number of genes down-regulated in clade B
Figure 2. a. Scatter plot analysis of the changes in synaptic plasticity gene expression in clade B infected astrocytes. Pair wise
comparison of control primary human astrocytes (No HIV infection) and clade B infected astrocytes by scatter plot analysis. Spots associated with
individual human synaptic plasticity gene were collected and converted into log10 scale. The central line indicates unchanged gene expression. The
synaptic plasticity genes with expression levels higher or lower in clade B infected astrocytes than the control cells are expected to produce dots that
deviate from the centerline. b. Scatter plot analysis of the changes in synaptic plasticity gene expression in clade C infected astrocytes.
Pair wise comparison of control primary human astrocytes (No HIV infection) and clade C infected astrocytes by scatter plot analysis. Spots associated
with individual human synaptic plasticity gene were collected and converted into log10 scale. The central line indicates unchanged gene expression.
The dots are allocated to positions that are above or below than the +3 fold or 23 fold line when the differences are greater than three folds.
doi:10.1371/journal.pone.0061399.g002
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infected astrocytes according to their functional category, 12
immediate early response genes, 11 long term potentiation, 8
Postsynaptic density, 7 long term depression, 6 neuronal receptor,
5 CREB factors and 3 cell adhesion functional genes were down-
regulated. Although each of these down-regulated genes has its
own role in the development of memory, cognitive and motor
functions, in this study, we have further analyzed the expression
profile of three dendritic spine density regulatory proteins and
further, the dendrite spine morphology changes in clade B and C
infected SK-N-MC neuroblastoma cells. In this study, in PCR
array, total 8 postsynaptic density regulatory genes (ADAM10,
ARC, DLG4 (PSD95), GRIA1, NMDAR1, GRIN2B, GRM1,
PICK1) were significantly down-regulated in clade B infected
astrocytes than control and clade C infected cells. Out of these,
important role of ARC, NMDAR1 and GRM1 in the mainte-
nance of synaptic density and dendritic architecture have been
well documented. An activity-regulated cytoskeleton-associated
protein is an ideal candidate for regulating spine morphology and
network stability [33]. Its expression is tightly regulated by
neuronal activity [34,35], and its RNA and protein are localized
to dendrites and spines after activity [36,37,38,39]. Furthermore,
ARC induction is required for late LTP and memory consolida-
Table 2. Human synaptic plasticity genes down-regulated in HIV-1 clade B & C infected primary human astrocytes (fold down
regulation): Out of 84 genes analyzed, only the genes significantly ($3 fold) down-regulate were shown in this table.
Synaptic plasticity genes Clade B fold change Clade C fold change p-value
ADAM104,5,8 23.5 22.9 ,0.005
AKT16 215.31 26.8 ,0.001
ARC1,8 23.2 22.6 ,0.024
CAMK2A2 23.7 23.4 ,0.001
CDH22,4 23.8 23.5 ,0.018
CEBPB1 24.3 22.7 ,0.001
CEBPD1 28.3 26.2 ,0.001
CNR12 29.4 27.3 ,0.001
CREB11 23.5 22.1 ,0.001
DLG48 29 27.4 ,0.001
EGR11 23.1 22.1 ,0.002
FOS1 28.3 25.1 ,0.001
GABRA52,7 23.5 24 ,0.002
GRIA12,3,7,8 241 228 ,0.001
NMDAR1 (GRIN1/NR1)2,6,7,8 23.2 22.6 ,0.024
GRIN2B2,4,6,7,8 24.7 21.6 ,0.001
GRM13,7,8 23.1 22.7 ,0.024
GRM87 23.6 23.4 ,0.020
JUN11 25.1 23.1 ,0.001
JUNB1 27.3 24.8 ,0.002
MAPK12,3,6 25.1 24.1 ,0.005
NFKBIB1 23.1 22.9 ,0.001
NGFR3 223.2 216.6 ,0.001
NPTX21 218.7 227 ,0.001
PICK13,8 25.7 24.2 ,0.004
PLCG12 210.2 29.3 ,0.001
PPP1CA2,3,6 232.6 218.3 ,0.001
PRKCA2,3 24.7 23.4 ,0.001
RELA1 24.1 23.5 ,0.001
SIRT19 23.1 22.5 ,0.001
SRF1 26 23.7 ,0.001
1Immediate-Early Response Genes (IEGs);
2Long Term Potentiation (LTP);
3Long Term Depression (LTD);
4Cell Adhesion;
5Extracellular Matrix & Proteolytic Processing;
6CREB Cofactors;
7Neuronal Receptors;
8Postsynaptic Density;
9Others.
doi:10.1371/journal.pone.0061399.t002
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tion [40,41,42]. NMDA receptor 1 is an essential gene for the
maintenance of spine density [43,44] and NR1 knockdown in
cultures results in unstable spines and reduced spine density [44].
Different studies using in vitro and in vivo models support the
important regulatory role of GRM1 receptors in neuronal
dendritic and spine morphology [45,46,47]. Therefore, these
three genes (ARC, NMDAR1, GRM1) were selected for further
flow cytometry analysis. In the flow-cytometry analysis, we have
observed that the levels of these three proteins were significantly
down regulated in clade B infected cells than control and clade C
infected primary human astrocytes and SK-N-MC neuroblastoma
cells indicating more dendrite morphological changes in the clade
B infected neuronal cells.
Further, in the confocal microscopic analysis of HIV infected
SK-N-MC neuroblastoma cells, numerous changes in dendritic
architecture have been observed which includes decreased
synaptic density, dendrite area and diameter; loss of dendritic
Table 3. Human synaptic plasticity genes up-regulated in
HIV-1 clade B & C infected primary human astrocytes (fold up
regulation).
Gene clade B clade C
EGR21 3.1 3.2
EGR41 8.3 4.4
HOMER11,3 3 3
INHBA2 4 4.5
SYNPO2,3 3 3.2
1Immediate-Early Response Genes (IEGs);
2Late Response Genes;
3Postsynaptic Density.
doi:10.1371/journal.pone.0061399.t003
Figure 3. Flow-cytometry analysis of postsynaptic density and dendrite morphology regulatory proteins. Levels of ARC, NMDAR1 and
GRM1 proteins were measured in clade B and C infected astrocytes by flow-cytometry. The expression levels of these three proteins were significantly
less in clade B infected astrocytes than clade C (p,0.02) infected and uninfected control cells (p,0.001).
doi:10.1371/journal.pone.0061399.g003
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spines, decreased spine area and length in clade B infected SK-N-
MC cells than control and clade C infected cells. Dendritic spines
are tiny protrusions along dendrites, which constitute major
postsynaptic sites for excitatory synaptic transmission. These
spines are highly motile and can undergo remodeling even in
the adult nervous system. Spine remodeling and the formation of
new synapses are activity dependent processes that provide a basis
for memory formation. A loss or alteration of these structures has
been described in patients with neurodegenerative disorders such
as Alzheimer’s disease [48,49]. Dendrite diameter also plays an
important role in maximizing the effectiveness of the synaptic
input [50]. Therefore, altered dendrite and spine morphology and
Figure 4. Confocal Images of DiI stained SK-N-MC cells. (4a) Control SK-N-MC cells: High number of long spines on the dendritic length, high
dendrite diameter, total dendrite area and spine area. (4b) Clade B infected cells: Loss of spines on the dendrite length, decreased dendrite diameter,
dendrite and spine area was observed than the control and clade C infected SK-N-MC cells. (4c) Clade C infected cells: Loss of number of spines,
decreased dendrite diameter, dendrite area and spine area was observed than control cells.
doi:10.1371/journal.pone.0061399.g004
Figure 5. Dendrite morphology changes in HIV-1 clade B and clade C infected SK-N-MC neuroblastoma cells. SK-N-MC neuroblastoma
cells were grown onto the glass coverslips and infected with the HIV clade B and C for 7 days. Cover slips were stained with the DiI stain and observed
under confocal microscopy. Randomly selected pictures in each group of the cells were captured in confocal microscope. Image J software was used
to analyze the total dendrite area (5a), spine density (5b), dendrite diameter (5c), spine area (5d), spine length (5e) and number of spines (5f).
doi:10.1371/journal.pone.0061399.g005
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number of spines may negatively affect the synaptic plasticity in
clade B and C infected patients. In the neurodegenerative process
of HIV encephalitis, synaptic and dendritic damage in the early
stages that progresses to neuronal loss in the neocortex, limbic and
striato-nigral systems [51,52,53,54,55,56] has been reported.
Therefore, this study indicates that HIV-1 clade B infection
results in decreased number of spines and altered dendrite
morphology than clade C infection that may lead to the decreased
synaptic plasticity.
Apoptosis of neuronal cells in HIV-1 infected individuals relates
to cognitive and motor dysfunctions [57,58]. The factors initiating
HAD seem to be pleotropic and include HIV-1 infection of certain
CNS-based cell types that may compromise their natural functions
and further lead to the release of viral particles or proteins that
trigger apoptosis of neurons [59,60,61]. Alternatively, the infection
of macrophages or microglia may enhance the release of pro-
inflammatory cytokines such as tumor necrosis factor (TNF-a) and
IFN-d, which are toxic to neurons [62,63]. As we have expected,
induction of astrocyte cell death was significantly higher in HIV-1
clade B infected astrocytes when compared to the clade C infected
cells. In conclusion, our results indicate that HIV-1 clade C is less
neuropathogenic than clade B. A recent study to investigate HIV-1
clades specific neuropathogenesis using the severe combined
immune deficiency (SCID) mouse HIV encephalitis model
indicated that infection with HIV-1 clade C resulted in a milder
cognitive dysfunction compared to HIV-1 clade B [64]. Results
from clinical studies on development of HIV-associated neuro-
cognitive impairment have suggested that HIV subtypes might
differ in biological properties with respect to their capacity to cause
HAND [65]. Further, it is possible that synaptic plasticity gene
down-regulation, changes in dendritic architecture and induction
of astrocyte apoptosis in clade B infected CNS cells compared to
clade C may be responsible for increased incidence of HAND in
clade B infected patients.
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